Message from the NLA President: Matthew Ito, PharmD
Thank you! It will be an honor to serve as your next President of the NLA. I am looking forward to working with our Board of Directors in the continued growth of our organization to meet the educational and scientific needs of you and your patients. The NLA and the Foundation of the NLA have made tremendous efforts to increase awareness of and to develop educational programs around Familial Hypercholesterolemia (FH), including publishing a consensus statement in the Journal of Clinical Lipidology in 2011. My goal as President is to build upon these efforts.
We are developing several initiatives that I hope you will find of interest. In particular, we plan to make FH a major focus of the 2014 Annual Scientific Sessions, which will be held May 1-4 in Orlando. We also are partnering with the AHA to develop a scientific statement on pediatric FH, which will be led by the NLA's Dr. Sam Gidding. In addition, collaborations are underway with the FH Foundation, which will host the FH Summit: Awareness to Action, on September 19 in Annapolis. This Summit will bring together various FH stakeholders to emphasize cooperation and best practices. This October we will convene a statin safety expert panel to be chaired by Dr. Terry Jacobson. We recently received funding from Merck & Co. to study how electronic health records can be used to improve LDL-C goal attainment. This project will be chaired by Dr. Jerome Cohen and me. We hope that these continued efforts by the NLA will reduce the devastating effects of FH.
Again, thank you for this opportunity, and I look forward to serving as your NLA President.